Skip to main content
OpenTrials

Clinical trial condition

High-risk Myelodysplastic Syndrome

Explore clinical trials studying High-risk Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

9 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

High-risk Myelodysplastic Syndrome trial results

Recruiting

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

NCT06994676

Conditions
AML - Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +17 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Medical Center Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern Medicine Chicago, Illinois, United States
View Trial Details
Recruiting

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

NCT06034275

Conditions
Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, Bone Marrow Diseases, +24 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • TriStar Bone Marrow Transplant Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Enrolling by Invitation

RVU120 Rollover Study

NCT06987058

Conditions
Acute Myeloid Leukaemia (AML), Advanced Solid Tumors, Bone Marrow Diseases, +15 more
Locations
  • Uniwersyteckie Centrum Kliniczne Gdansk, Poland
  • Clinica Universidad de Navarra Pamplona, Spain
View Trial Details
Completed

Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes

NCT03824080

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • CHU Hôtel Dieu Service d'Hématologie Clinique Nantes, Nantes Cedex 1, France
  • Service d'Hématologie Séniors Paris, Paris 7, France
  • Hôpital Archet 1 Service d'Hématologie Clinique Nice, France
  • Universitätsklinikum Dresden Dresden, Germany
View Trial Details
Active, Not Recruiting

A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

NCT04217278

Conditions
Acute Myeloid Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • University Hospitals Bristol Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • University Hospital of Wales Cardiff, United Kingdom
View all 14 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

NCT06268574

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Centre Hospitalier Universitaire Grenoble Alpes La Tronche, France
  • Centre Hospitalier Le Mans Le Mans, France
  • Centre Hospitalier Universitaire de Lille (CHU Lille) Lille, France
  • Institut Paoli Calmettes (IPC) Marseille, France
View all 41 locations
View Trial Details

Related conditions